Tags |
|
|
Links |
|
|
Digg It - Traffic Exchanges - Do you love or hate Traffic Exchanges?
The people that hate them…
These people have usually tried one or more traffic exchanges to promote their main business and found that they get low to n
These people have usually tried one or more traffic exchanges to promote their main business and found that they get low to n
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
on-existent sales or signups for the amount of effort they put in.
This is not surprising since most TEs offer at best a 1:1 visitor/surf ratio (meaning you ha
This is not surprising since most TEs offer at best a 1:1 visitor/surf ratio (meaning you ha
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
e to view at least one member site to earn a visitor to your own site, often more for free memberships).
Someone using TEs for an untargeted ’proposition’ woul
Someone using TEs for an untargeted ’proposition’ woul
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
probably get a 0.01 - 0.1% conversion rate at best so they might have to view 10000 sites at least to make one conversion - no wonder they conclude they don’t
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ork. Yet the TE is working exactly as it should, it’s not the TEs fault if the conversion rate is so low.
The reason the conversion rate is so low is two-fold.
The reason the conversion rate is so low is two-fold.
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
One, the traffic is untargeted for their business (generally, see exceptions later) and two, the visitors are surfing to earn credits. Thus they don’t generally
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
want to take time out to look at a site unless it really interests them.
The people that love them…
The people that make TEs work have realised the abo
The people that love them…
The people that make TEs work have realised the abo
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
e problems and have gotten around them by exploiting a common feature of (virtually) all TEs - they all offer extra credits for referring other people to the TE
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
- i.e. building a downline in that TE.
So these people diligently build downlines in one or more TEs so that they earn a lot more credits per month than they c
So these people diligently build downlines in one or more TEs so that they earn a lot more credits per month than they c
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
uld ever earn by surfing alone.
If these people are using the resulting credits to promote the same kind of proposition as above with a 0.01-0.1% conversion ra
If these people are using the resulting credits to promote the same kind of proposition as above with a 0.01-0.1% conversion ra
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
e, that rate doesn’t change but the number of free credits results in conversions.
They take the view that the way to work with a low conversion rate is to get
They take the view that the way to work with a low conversion rate is to get
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
a lot more traffic and building a downline is the way to do that. So rather than decide the problem is untargeted traffic and concluding traffic exchanges are
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
seless for their proposition, they up the ante by getting much more traffic.
Of course, some will see this as wasteful - why not just use targeted advertising?
Of course, some will see this as wasteful - why not just use targeted advertising?
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
On the other hand, build a downline in traffic exchanges and you can have a source of free, albeit untargeted traffic and since it’s free, it’s cost-effective d
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
spite the low conversion rate.
I said that TE traffic is relatively untargeted for most businesses but there are exceptions. In fact there are three notable on
I said that TE traffic is relatively untargeted for most businesses but there are exceptions. In fact there are three notable on
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
s:
- If your proposition is about making money
- If your proposition is about getting more from TEs
- If your proposition is ‘free’ pro
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ucts or information
Most of the people surfing to earn credits are doing it to promote a business - they’re interested in making money. These people
Most of the people surfing to earn credits are doing it to promote a business - they’re interested in making money. These people
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
may already have a business but they’re usually open to other ways of making money.
The people surfing are using TEs to earn credits so anything that offers th
The people surfing are using TEs to earn credits so anything that offers th
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
m a way to increase the credits they earn is going to appeal to a lot of them.
And if something is free, they may as well have it.
There are other tips to get
And if something is free, they may as well have it.
There are other tips to get
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ing more from traffic exchanges but design your strategy around these 3 high-conversion areas and you might find that traffic exchanges could help you after all
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/81529/diggit-Traffic-Exchanges--Do-you-love-or-hate-Traffic-Exchanges.html">Traffic Exchanges - Do you love or hate Traffic Exchanges?</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/81529/diggit-Traffic-Exchanges--Do-you-love-or-hate-Traffic-Exchanges.html]Traffic Exchanges - Do you love or hate Traffic Exchanges?[/url]
Related Articles:
Time-Wasting Problems - One Question to Move You Forward
The Importance Of Writing A Good Cover Letter
Bookmark it:
|